2016
Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic FexCo1‐xFe2O4 nanoensembles
Hoque SM, Huang Y, Cocco E, Maritim S, Santin AD, Shapiro EM, Coman D, Hyder F. Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic FexCo1‐xFe2O4 nanoensembles. Contrast Media & Molecular Imaging 2016, 11: 514-526. PMID: 27659164, DOI: 10.1002/cmmi.1713.Peer-Reviewed Original Research
2015
Reply
Santin AD, Roque DM. Reply. American Journal Of Obstetrics And Gynecology 2015, 213: 881. PMID: 26292047, DOI: 10.1016/j.ajog.2015.08.029.Peer-Reviewed Original ResearchUse of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents
Miller DT, Roque DM, Santin AD. Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents. American Journal Of Obstetrics And Gynecology 2015, 212: 725-735. PMID: 25577672, PMCID: PMC4457701, DOI: 10.1016/j.ajog.2014.12.029.Peer-Reviewed Original ResearchMeSH KeywordsFemaleFerric CompoundsHemostaticsHumansPostpartum HemorrhagePregnancySulfatesYoung AdultConceptsTopical hemostatic agentsMonsel's solutionHemostatic agentsAbnormal placentationFuture fertilityFocal placenta accretaPelvic artery embolizationSuccessful uterine preservationExcessive blood lossTime of deliveryResource-poor nationsObstetric surgeryPeripartum hemorrhageUterine preservationArtery embolizationCesarean hysterectomyPlacenta accretaBalloon tamponadeBlood lossMaternal deathsObstetrical hemorrhageAdverse sequelaePlacental bedCompression suturesSide effects